複数の頭痛が多発する.

Juan Gomez-Alonso

Lancet (London, England)

|June 13, 2006

まとめ

No abstract available in PubMed .

関連する概念動画

こちらも読む

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え

Same author

Surgical treatment for drug-resistant epilepsy.

JAMA·2015

Same author

Epilepsy surgery trends in the United States, 1990-2008.

Neurology·2012

Same author

Treatment of refractory mesial temporal lobe epilepsy.

JAMA·2012

Same author

[The new International League Against Epilepsy (ILAE) classification of epilepsies: a step in the wrong direction?].

Revista de neurologia·2011

Same author

[Focal refractory epilepsy: medical or surgical treatment?].

Revista de neurologia·2011

Same author

A graded system to categorize drug-resistant epilepsy.

Epilepsia·2010

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

関連する実験動画

複数の頭痛が多発する.

関連する概念動画

Surgical treatment for drug-resistant epilepsy.

Epilepsy surgery trends in the United States, 1990-2008.

Treatment of refractory mesial temporal lobe epilepsy.

[The new International League Against Epilepsy (ILAE) classification of epilepsies: a step in the wrong direction?].

[Focal refractory epilepsy: medical or surgical treatment?].

A graded system to categorize drug-resistant epilepsy.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

複数の頭痛が多発する.

関連する概念動画

Surgical treatment for drug-resistant epilepsy.

Epilepsy surgery trends in the United States, 1990-2008.

Treatment of refractory mesial temporal lobe epilepsy.

[The new International League Against Epilepsy (ILAE) classification of epilepsies: a step in the wrong direction?].

[Focal refractory epilepsy: medical or surgical treatment?].

A graded system to categorize drug-resistant epilepsy.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

複数の頭痛が多発する.

関連する概念動画

関連記事

Surgical treatment for drug-resistant epilepsy.

Epilepsy surgery trends in the United States, 1990-2008.

Treatment of refractory mesial temporal lobe epilepsy.

[The new International League Against Epilepsy (ILAE) classification of epilepsies: a step in the wrong direction?].

[Focal refractory epilepsy: medical or surgical treatment?].

A graded system to categorize drug-resistant epilepsy.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

複数の頭痛が多発する.

関連する概念動画

関連記事

Surgical treatment for drug-resistant epilepsy.

Epilepsy surgery trends in the United States, 1990-2008.

Treatment of refractory mesial temporal lobe epilepsy.

[The new International League Against Epilepsy (ILAE) classification of epilepsies: a step in the wrong direction?].

[Focal refractory epilepsy: medical or surgical treatment?].

A graded system to categorize drug-resistant epilepsy.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.